Skip to main content
Fig. 1 | BMC Psychiatry

Fig. 1

From: Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations

Fig. 1

Selection of the study population. Abbreviations: LAI, long-acting injectable; OAT, oral antipsychotic therapy; PP, paliperidone palmitate; REACH-OUT, Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes study. Notes: Reasons for REACH-OUT ineligibility (N = 99) included unknown or ineligible age (N = 34, 34%), most recent antipsychotic unknown or not study-eligible (N = 22, 22%), did not meet diagnostic criteria for schizophrenia or bipolar I disorder (N = 18, 18%), patient unwilling to complete scheduled study interviews (N = 17, 17%), patient participating in concurrent clinical study (N = 4, 4%), and patient did not consent (N = 4, 4%)

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us